Predictive factors for the development of irinotecan-related cholinergic syndrome using ordered logistic regression analysis
Sign Up to like & getrecommendations! Published in 2018 at "Medical Oncology"
DOI: 10.1007/s12032-018-1142-3
Abstract: Cholinergic syndrome is an acute adverse reaction associated with irinotecan. Development of cholinergic syndrome can be ameliorated or prevented by administering various anticholinergics, including atropine sulfate or scopolamine butylbromide. Although many of the side effects… read more here.
Keywords: analysis; development irinotecan; cholinergic syndrome; syndrome ... See more keywords